Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus® Auto-Injector

Thursday, May 05, 2022

Stevanato Group SpA a global provider of drug containment drug delivery and diagnostic solutions to the pharmaceutical biotechnology and life sciences industries has signed an exclusive agreement with leading medical device developer and manufacturer...

CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development

Wednesday, May 04, 2022

CYTENA a BICO group company and a leading provider of highprecision instruments for handling biological cells has entered a collaboration agreement with ExcellGene SA a leading biologics CDMO that manufactures recombinant proteins Together the compan...

Agastiya Biotech receives FDA Orphan Drug Designation for AB001 for Pancreatic cancer and Acute Myeloid Leukemia (AML)

Wednesday, May 04, 2022

Agastiya Biotech and Vopec Pharmaceuticals announce that the US FDA has granted Orphan Drug Designations for Pancreatic Cancer and AML for its novel small molecule AB AB is a small molecule PDL checkpoint inhibitor that also targets aberrant intrac...

Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar

Tuesday, May 03, 2022

Endo International plc announced today that its subsidiary Endo Ventures Limited EVL acquired six developmentstage readytouse injectable product candidates from Nevakar Injectables Inc a subsidiary of Nevakar Inc These six product candidates that wou...

Nicoya Completes Acquisition of LSK Technologies, Expanding Digital Platform into Molecular Testing

Tuesday, May 03, 2022

Nicoya Lifesciences a global innovator of digital proteomics solutions for diagnostics and biotherapeutic discovery today announced the acquisition of LSK Technologies a University of Toronto startup decentralizing laboratory testing with their hight...

Inmagene Receives FDA's IND Clearance for OX40 Antagonist

Monday, May 02, 2022

Inmagene Biopharmaceuticals announces that the US Food and Drug Administration FDA has cleared drug candidate IMG a monoclonal antibody against OX to proceed to Phase I clinical development Inmagene is developing IMG in partnership with HUTCHMED Chin...

GC Biopharma Concludes Agreement With Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics

Friday, April 29, 2022

GC Biopharma and Acuitas Therapeutics a company focused on developing lipid nanoparticle LNP delivery systems to enable messenger RNA mRNAbased therapeutics today announced that they have entered into a Development and Option agreement for Acuitas LN...

Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions

Friday, April 29, 2022

Plexium Inc Plexium and AbbVie have entered into an exclusive strategic collaboration to develop and commercialize novel Targeted Protein Degradation TPD therapeutics for neurological conditions This collaboration combines AbbVies extensive neuroscie...

Serenity Bioworks Acquires DC-TAB for Lupus Nephritis

Thursday, April 28, 2022

Serenity Bioworks announces today it has completed the acquisition of DCTAB a recombinant human HspB that was previously in clinical development for relapseremitting multiple sclerosis Included in the transaction are the manufacturing material toxico...

Virpax Successfully Completes Initial Preclinical Studies for VRP324

Thursday, April 28, 2022

Virpax Pharmaceuticals Inc a company specializing in developing nonaddictive product candidates for pain management CNS disorders and antiviral indications reported preclinical pharmacokinetics PK results for VRP METCBD a nosetobrain delivery platfor...